Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) Income from Continuing Operations (2016 - 2018)

Achieve Life Sciences (ACHV) has disclosed Income from Continuing Operations for 7 consecutive years, with 3637000.0 as the latest value for Q4 2018.

  • Quarterly Income from Continuing Operations rose 2.75% to 3637000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 12687000.0 through Dec 2018, up 6.95% year-over-year, with the annual reading at 16395000.0 for FY2019, 29.23% down from the prior year.
  • Income from Continuing Operations for Q4 2018 was 3637000.0 at Achieve Life Sciences, down from 3240000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 166000.0 in Q2 2017, with the low at 9400000.0 in Q3 2017.
  • Average Income from Continuing Operations over 4 years is 2597727.27, with a median of 2788000.0 recorded in 2018.
  • The sharpest move saw Income from Continuing Operations plummeted 2220.99% in 2017, then soared 65.53% in 2018.
  • Achieve Life Sciences' Income from Continuing Operations stood at 1235000.0 in 2015, then surged by 50.36% to 613000.0 in 2016, then tumbled by 510.11% to 3740000.0 in 2017, then rose by 2.75% to 3637000.0 in 2018.
  • Per Business Quant, the three most recent readings for ACHV's Income from Continuing Operations are 3637000.0 (Q4 2018), 3240000.0 (Q3 2018), and 2788000.0 (Q2 2018).